NEA Management Company, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), NEA Management Company, LLC reported 41 stock positions worth $1.3 billion. Its top holding was Arcellx (ACLX) at 15.6% of the portfolio, followed by Tempus AI Class A (TEM, 12.0%) and Rhythm Pharmaceuticals (RYTM, 9.0%). Compared with Q1 2024, it opened 1 new position, sold out of 4, added to 3 and reduced 2. The biggest buy was a new position in Tempus AI Class A (TEM) and the biggest sale Geron (GERN, shares −78%).

Most Recent 13F
Q2 2026
Location
TIMONIUM, MD
CIK
0001512848
Portfolio Value
$1.3B (Q2 2024)
SEC Filing
0001012975-24-000337 ↗ filed Aug 14, 2024

Holdings Value

0$500.0M$1.0B$1.5B$2.0B Q1 2024: $1.6B Q1 2024 Q2 2024: $1.3B $1.3B Q2 2024 Q3 2024: $1.8B Q3 2024 Q4 2024: $1.8B Q4 2024 Q1 2025: $1.3B Q1 2025 Q2 2025: $1.3B Q2 2025 Q3 2025: $1.8B Q3 2025 Q4 2025: $2.0B Q4 2025 Q1 2026: $1.8B Q1 2026 Q2 2026: $1.6B Q2 2026

Holdings 41 stocks · $1.3B
ACLX Arcellx Inc. 15.55% 3,745,262 $206.7M No change
TEM Tempus AI Inc. Class A 12.04% 4,572,810 $160.0M New
RYTM Rhythm Pharmaceuticals Inc. 8.99% 2,909,956 $119.5M No change
SVRA Savara Inc. 7.42% 24,471,264 $98.6M No change
COUR Coursera Inc. 6.93% 12,867,769 $92.1M No change
CRSP Crispr Therapeutics AG 6.45% 1,587,854 $85.8M No change
VRNA Verona Pharma Ltd. 6.08% 5,584,753 $80.8M Add +9.3%
NN Nextnav Inc. 5.00% 8,189,156 $66.4M No change
KRRO Korro Bio Inc. 2.78% 1,090,793 $36.9M Add +1.7%
TRVI Trevi Therapeutics Inc. 2.55% 11,370,376 $33.9M No change
GLUE Monte Rosa Therapeutics Inc. 2.16% 7,692,298 $28.8M No change
CVRX CVRX Inc. 2.14% 2,370,542 $28.4M No change
AUPH Aurinia Pharmaceuticals Inc. 1.71% 3,969,834 $22.7M No change
NKTX Nkarta Inc. 1.59% 3,568,781 $21.1M No change
BDTX Black Diamond Therapeutics I 1.56% 4,448,757 $20.7M No change
CELC Celcuity Inc. 1.54% 1,250,001 $20.5M No change
PHAT Phathom Pharmaceuticals Inc. 1.52% 1,960,169 $20.2M No change
ADAPY Adaptimmune Therapeutics-ADR 1.25% 17,079,778 $16.7M No change
GOSS Gossamer Bio Inc. 1.23% 18,093,034 $16.3M Add +14.2%
NEUE Neuehealth Inc. 1.12% 2,726,917 $14.8M No change
GERN Geron Corp. 0.89% 2,776,409 $11.8M Reduce -78.3%
RGLS Regulus Therapeutics Inc. 0.87% 6,467,802 $11.6M No change
INZY Inozyme Pharma Inc. 0.82% 2,437,689 $10.9M No change
ORIC Oric Pharmaceuticals Inc. 0.80% 1,500,000 $10.6M No change
BZFD Buzzfeed Inc. 0.80% 3,833,473 $10.6M No change
MYND Mynd.ai Inc. 0.76% 3,642,711 $10.1M No change
CSBR Champions Oncology Inc. 0.67% 1,713,720 $8.9M No change
XFOR X4 Pharmaceuticals Inc. 0.65% 14,986,793 $8.7M No change
RENEO PHARMACEUTICALS INC 0.54% 4,785,494 $7.2M No change
SGMT Sagimet Biosciences Inc. Class A 0.51% 2,000,275 $6.8M No change
ALLK Allakos LLC 0.46% 6,147,260 $6.1M No change
DM Desktop Metal Inc. Class A 0.45% 1,439,892 $5.9M No change
MRKR Marker Therapeutics Inc. 0.44% 1,071,428 $5.8M No change
TUYA Tuya Inc. 0.42% 3,260,976 $5.6M Reduce -33.9%
SYBX Synlogic Inc. 0.33% 2,922,772 $4.4M No change
IVA Inventiva SA - ADR 0.33% 1,462,586 $4.4M No change
LXRX Lexicon Pharmaceuticals Inc. 0.30% 2,382,286 $4.0M No change
AFMDQ Affimed NV 0.18% 442,649 $2.4M No change
SNTI Senti Biosciences Inc. 0.09% 4,426,151 $1.2M No change
IKENA ONCOLOGY INC 0.07% 570,050 $941K No change
UP Wheels Up Experience Inc. 0.02% 106,125 $201K No change

Portfolio Sells Q1 2024 → Q2 2024
GERN Geron Corp. Reduce -78.3% 0.89% −1.73
ZFOX Zerofox Holdings Inc. Sold out 0.00% −1.26
GLYCOMIMETICS INC Sold out 0.00% −0.71
TUYA Tuya Inc. Reduce -33.9% 0.42% −0.12
XERS Xeris Biopharma Holdings Inc. Sold out 0.00% −0.06
SRFM Surf Air Mobility Inc. Com New Sold out 0.00% −0.01

Portfolio Buys Q1 2024 → Q2 2024
TEM Tempus AI Inc. Class A New 12.04% +12.04
VRNA Verona Pharma Ltd. Add +9.3% 6.08% +0.50
GOSS Gossamer Bio Inc. Add +14.2% 1.23% +0.07
KRRO Korro Bio Inc. Add +1.7% 2.78% −3.21

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 26$1.6BTRVI, MBX, GLUE, CELC, SGP
Q1 2026 26$1.8BACLX, CELC, SGP, TRVI, SVRA
Q4 2025 27$2.0BCELC, RYTM, ACLX, TRVI, SVRA
Q3 2025 29$1.8BRYTM, ACLX, VRNA, COUR, TRVI
Q2 2025 32$1.3BACLX, VRNA, RYTM, COUR, CRSP
Q1 2025 37$1.3BACLX, VRNA, RYTM, TEM, COUR
Q4 2024 41$1.8BACLX, VRNA, TEM, RYTM, NN
Q3 2024 42$1.8BACLX, TEM, VRNA, RYTM, SVRA
Q2 2024 41$1.3BACLX, TEM, RYTM, SVRA, COUR
Q1 2024 44$1.6BACLX, CRSP, RYTM, SVRA, COUR